Arnold-Chiari malformation pathophysiology

Revision as of 14:34, 16 September 2019 by Fahimeh Shojaei (talk | contribs)
Jump to navigation Jump to search

Arnold-Chiari malformation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Arnold-Chiari malformation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Case #2

Arnold-Chiari malformation pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Arnold-Chiari malformation pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Arnold-Chiari malformation pathophysiology

CDC on Arnold-Chiari malformation pathophysiology

Arnold-Chiari malformation pathophysiology in the news

Blogs on Arnold-Chiari malformation pathophysiology

Directions to Hospitals Treating Arnold-Chiari malformation

Risk calculators and risk factors for Arnold-Chiari malformation pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

The exact pathogenesis of Arnol-Chiari malformation is not fully understood but It is thought that Arnol-Chiari malformation is the result of bone developmental abnormalities or mesodermal growth and differentiation abnormalities. Genes involved in the pathogenesis of Arnold-Chiari malformation include PAX1, PAX2, PAX3, PAX6, FGF2, TBX6, HOX gene, Noggin gene, and EFNB1.

Pathophysiology

Pathogenesis

  • The exact pathogenesis of Arnol-Chiari malformation is not fully understood but It is thought that Arnol-Chiari malformation is the result of cascade of anomalies that lead to:
    • Bone developmental abnormalities
    • Mesodermal growth and differentiation abnormalities
  • These anomalies can be congenital as a result of developmental error or acquired.
  • All the potential causes of Chiari malformation will lead to posterior cranial fossa abnormalities and subsequently herniation of cerebellar and/or other structures from foramen magnum.

Genetics

  • Genes involved in the pathogenesis of Arnold-Chiari malformation include:[1]
    • PAX1
    • PAX2
    • PAX3
    • PAX6
    • FGF2
    • TBX6
    • HOX gene
    • Noggin gene
    • EFNB1
  • There are many findings emphasizing on genetic basic of Chiari malformation including:
    • Many studies described higher prevalence of Chiari malformation among mono zygote twins or between family members.
    • There are some evidence showing autosomal dominant/ recessive transmission.
    • There are many genetic conditions that have association with Chiari malformation.

Associated Conditions

Conditions associated with Arnold-Chiari malformation include:[2][3][4][5][6]

Gross Pathology

On gross pathology, there is no characteristic finding of Chiari malfromation.

Microscopic Pathology

On microscopic pathology, there is no characteristic finding of Chiari malfromation.


References

  1. Schanker, Benjamin D.; Walcott, Brian P.; Nahed, Brian V.; Kahle, Kristopher T.; Li, Yan Michael; Coumans, Jean-Valery C. E. (2011). "Familial Chiari malformation: case series". Neurosurgical Focus. 31 (3): E1. doi:10.3171/2011.6.FOCUS11104. ISSN 1092-0684.
  2. "Neuropathology For Medical Students".
  3. Milhorat TH, Bolognese PA, Nishikawa M, McDonnell NB, Francomano CA (2007). "Syndrome of occipitoatlantoaxial hypermobility, cranial settling, and chiari malformation type I in patients with hereditary disorders of connective tissue". Journal of Neurosurgery: Spine. 7 (6): 601–9. doi:10.3171/SPI-07/12/601. PMID 18074684. Unknown parameter |month= ignored (help)
  4. Holder-Espinasse M, Abadie V, Cormier-Daire V, Beyler C, Manach Y, Munnich A, Lyonnet S, Couly G, Amiel J (October 2001). "Pierre Robin sequence: a series of 117 consecutive cases". J. Pediatr. 139 (4): 588–90. doi:10.1067/mpd.2001.117784. PMID 11598609.
  5. Tubbs RS, Rutledge SL, Kosentka A, Bartolucci AA, Oakes WJ (April 2004). "Chiari I malformation and neurofibromatosis type 1". Pediatr. Neurol. 30 (4): 278–80. doi:10.1016/j.pediatrneurol.2003.09.013. PMID 15087107.
  6. Schanker, Benjamin D.; Walcott, Brian P.; Nahed, Brian V.; Kahle, Kristopher T.; Li, Yan Michael; Coumans, Jean-Valery C. E. (2011). "Familial Chiari malformation: case series". Neurosurgical Focus. 31 (3): E1. doi:10.3171/2011.6.FOCUS11104. ISSN 1092-0684.
  7. Holder-Espinasse M, Winter RM (October 2003). "Type 1 Arnold-Chiari malformation and Noonan syndrome. A new diagnostic feature?". Clin. Dysmorphol. 12 (4): 275. doi:10.1097/01.mcd.0000081505.97834.0a. PMID 14564218.


Template:WH Template:WS